Rubix LS
Biotechnology ResearchMassachusetts, United States2-10 Employees
Rubix LS: The Health Outcomes Architect Company At Rubix LS, we architect better health outcomes for every community—integrating clinical, biological, environmental, socio-economic, and geographic data upfront, and pairing it with inclusive, patient-centered research execution. Our work spans three core pillars: 🔹 Translational Bridging + Investigator‑Initiated Studies (IIS/IIT) – We close evidence gaps across early and late translational work to move programs from signal → feasibility → real‑world adoption. We design decision‑grade evidence for safety, effectiveness, access, and value—spanning pragmatic pilots, real‑world studies, Phase IV/RWE programs, HEOR, and SDoH & equity analytics. 🔹 Contract Research Organization (CRO) Services – End‑to‑end clinical research support from regulatory & early planning (pre‑IND) through Phase I–II execution, adaptive/decentralized designs, and compliant data & analytics (CDISC, 21 CFR Part 11). Our outcomes‑driven trials are built for representation and retention. 🔹 Federal Services & Public Health – We partner with federal agencies and public health organizations to tackle complex challenges in infectious disease, biodefense, and health equity—translating data into scalable programs, metrics, and policy‑ready insights. Powered by 18M+ patient data sets and 369M+ patient data points across clinical, genomic, environmental, and social factors. Leveraging Environmental & Geographic Insights ✅ DOE data to analyze long‑term environmental exposures ✅ USDA data to study how food and nutrition impact health ✅ Geographic risk models (including heat sinks) to understand cancer and environmental disease patterns At Rubix LS, we don’t just run studies—we architect pathways to measurable, equitable health impact. 🔗 Learn more at rubixls.com
1-888-653-2347 
support@leadiq.com 
